Our in vitro and in vivo results revealed a significant decrease in ATP5O protein levels in the DCM group, followed by a significant increase after pretreatment with CVB-D (Figs. 2 and 3). The gene discussed is ATP5PO; the disease is familial dilated cardiomyopathy.